Canada Pension Plan Investment Board
SNNA

Canada Pension Plan Investment Board’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

Canada Pension Plan Investment Board’s Portfolio SNNA Stock Details SNNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-30,000
Closed -$26K – 1343
2019
Q2 		$26K Buy
+30,000
New +$47K ﹤0.01% 1174

Other funds holding SNNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GSWM
Golden State Wealth Management Santa Ana, California $1.1B AUM 27.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Canada Pension Plan Investment Board's SNNA Position: Q3 2019 in Review

Canada Pension Plan Investment Board sold out of Sienna Biopharmaceuticals, Inc. (SNNA) in Q3 2019, closing a stake of 30,000 shares — an estimated $26K sold.

Canada Pension Plan Investment Board first reported a position in SNNA in Q2 2019 and held it in 1 quarter. The position peaked at $26K in Q2 2019. 23 funds tracked by Wall St. Rank hold SNNA as of Q3 2019.

  • Canada Pension Plan Investment Board reported no remaining Sienna Biopharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 30,000 Sienna Biopharmaceuticals, Inc. shares in Q3 2019, an estimated $26K.
  • Canada Pension Plan Investment Board first reported a position in Sienna Biopharmaceuticals, Inc. in Q2 2019 and held it in 1 quarter.
  • Canada Pension Plan Investment Board's Sienna Biopharmaceuticals, Inc. position peaked at $26K in Q2 2019.
  • 23 funds tracked by Wall St. Rank held Sienna Biopharmaceuticals, Inc. as of Q3 2019.

Based on Canada Pension Plan Investment Board's 13F filing for Q3 2019, filed 12 Nov 2019.